Skip to content

Source filing unavailable

Q3 2013 · —
Revenue$213.25M+1.5% vs Q3 2012+3.7% vs Q2 2013
Net Income-$30.33MN/M vs Q3 2012N/M vs Q2 2013
EPS Diluted-$1.09N/M vs Q3 2012N/M vs Q2 2013
Gross Profit$131,479,000+0.7%
Operating Income-$31,141,000N/M
Operating Cash Flowderived$30,808,000+10.4%
Free Cash Flowderived$17,561,000+114.4%
Margins · derived
Gross margin61.7%−0.5 pt vs Q3 2012
Operating margin-14.6%−24.0 pt vs Q3 2012
Net margin-14.2%−20.5 pt vs Q3 2012

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2013Q3 2012Q3 2011Q3 2010
Revenue$213.25M$210.08M$202.19M$186.64M
Net Income-$30.33M$13.21M$11.24M$16.48M
EPS Diluted-$1.09$0.46$0.39$0.55

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR